EP3478300

TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    29.6.2017
  • EP published:
    24.8.2022
  • EP application number:
    17819499.9
  • Max expiry date:
    28.6.2037
  • Title in English:
    TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH LONG ACTING GLATIRAMER AND ADIPOSE-DERIVED STEM CELLS
  • Language of the patent:
    English

Timeline

Today
29.6.2017EP application
24.8.2022EP Publication

Owner

  • Name:
    Stem Cell Medicine Ltd.
  • Address:
    5 Kiryat Hamada Street, 91451 Jerusalem, IL
  • Name:
    Mapi Pharma Limited
  • Address:
    16 Einstein Street Weizmann Science Park P.O. Box 4113, 74140 Ness Ziona, IL

Inventor

  • Name:
    MAROM, Ehud
  • Address:
    6107079 Tel Aviv, IL
  • Name:
    BLEICH KIMELMAN, Nadav
  • Address:
    6941617 Tel AVIV, IL
  • Name:
    GRYNSPAN, Frida
  • Address:
    90805 Mevasseret Zion, IL

Priority

  • Number:
    201662356543 P
  • Date:
    30.6.2016
  • Country:
    US

Classification

  • Categories:
    A61K 35/28, A61K 38/02, A61P 37/02

Upload documents